Havemeyer Place LP Buys Shares of 7,854 Teleflex Incorporated $TFX

Havemeyer Place LP acquired a new stake in Teleflex Incorporated (NYSE:TFX) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 7,854 shares of the medical technology company’s stock, valued at approximately $959,000.

A number of other large investors have also made changes to their positions in the company. AQR Capital Management LLC increased its position in shares of Teleflex by 478.1% in the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock valued at $287,603,000 after buying an additional 1,956,811 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Teleflex by 0.3% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,245,614 shares of the medical technology company’s stock valued at $152,408,000 after buying an additional 3,812 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Teleflex by 10.6% in the 4th quarter. Geode Capital Management LLC now owns 985,684 shares of the medical technology company’s stock valued at $120,312,000 after buying an additional 94,679 shares in the last quarter. Abrams Bison Investments LLC bought a new stake in shares of Teleflex in the 3rd quarter valued at $112,317,000. Finally, Thrivent Financial for Lutherans increased its position in shares of Teleflex by 40.6% in the 4th quarter. Thrivent Financial for Lutherans now owns 774,034 shares of the medical technology company’s stock valued at $94,463,000 after buying an additional 223,585 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. Truist Financial restated a “hold” rating and issued a $143.00 price objective (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. Needham & Company LLC upped their price objective on shares of Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. Zacks Research upgraded shares of Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Wells Fargo & Company upped their price objective on shares of Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. Finally, Wall Street Zen cut shares of Teleflex from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th. Three research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Teleflex presently has an average rating of “Hold” and a consensus target price of $144.00.

Teleflex Price Performance

Shares of NYSE TFX opened at $129.90 on Monday. The firm has a market cap of $5.75 billion, a PE ratio of -5.70, a PEG ratio of 0.97 and a beta of 0.82. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $139.67. The company has a fifty day moving average price of $127.08 and a 200 day moving average price of $118.14.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The firm had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company’s revenue for the quarter was up 32.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Research analysts predict that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, May 25th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s dividend payout ratio is presently -5.96%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.